• Skip to primary navigation
  • Skip to main content
  • Skip to footer
MiiSkin
  • Platform
    • Miiskin PRO App
    • Portal & Integrations
    • Miiskin PRO Pricing
    • Teledermatology Reimbursement
  • For Organizations
    • For Health Systems
    • For Independent Practices
    • For CRO’s
  • For Patients
    • Track your treatment results
    • Measure and track your moles
  • Resources
    • Providers: Telehealth
    • Providers: Healthcare
    • Providers: Clinic setup
    • Patients: Dermatology
    • Patients: Skin cancer
    • Patients: Melanoma
    • Patients: Moles
    • Patients: Acne
    • Patients: Acne medicine
    • Patients: User stories
  • Login
    • Provider Portal
    • Web Compare (patients)
    • Manage Premium (patients)
  • Schedule a demo
Home / dermatology / decentralized clinical trials

Decentralized Clinical Trials and Research in Dermatology 

Decentralized or hybrid clinical trials can make dermatology research more accessible to people from a broader demographic who may otherwise not participate in a site-based study.

Author: Jennifer Highland, Content Manager of Miiskin | Reviewed by:  Jon Friis, founder, and CEO of Miiskin

Covered in this article:
Definition  | Types | Benefits  | Platform


  • Share:
  • Facebook
  • Twitter
  • Reddit
  • Linkedin
  • Permalink

There have been significant changes in how the pharmaceutical industry develops medications and conducts clinical trials in dermatology and other medical specialties. Digital health solutions have been vital in adopting patient-centricity in clinical trials.

With increased costs and time to bring new drugs to market, the demand for hybrid or decentralized clinical trials (DCTs) in dermatology has risen.

virtual-clinical-trials-dermatology

Definition of Decentralized Clinical Trials

What are decentralized clinical trials? 

Decentralized clinical trials are defined as clinical studies with a focus on patient-centricity supported by mobile or digital health technologies to collect patient-reported data and outcomes. They can take place fully remote or hybrid, meaning patients must visit the research facility at least once.  

Hybrid or virtual clinical studies in dermatology are conducted remotely. Patients report data at home or from a suitable location closer to their home virtually and in-home clinical visits.

Read more:  FDA Guidance on Decentralized Clinical Trials and Clinical Trials Guidance Documents

miiskin for clinical dermatology research

Skin Health Platform for Clinical Research

Miiskin PRO empowers dermatology researchers to remotely collect patient-reported data during clinical studies.

LEARN MORE

Clinical Trials Types in Dermatology and Other Medical Specialties

There are three clinical trial types, traditional, decentralized, and hybrid. Hybrid or Virtual Dermatology Clinical Trials Meet Patients where they are.

research in dermatology

Fully Centralized (traditional)

  • All clinical study procedures are conducted at the research site

Hybrid (mixed)

  • Initial registration and complex procedures are conducted at the research site
  • Simple procedures that require in-person visits are conducted at an alternative or mobile site, while simple procedures take place remotely

Fully Decentralized (virtual)

  • All trial procedures take place virtually

Benefits of Virtual Clinical Trials in Dermatology

Remote clinical trials in dermatology can reduce the time and resources utilized, promote patient recruitment and engagement, decrease patient attrition, and increase patient diversity1.

The concept of meeting patients where they are when conducting clinical trials aims to increase the convenience and experience of patients.

Typically, 70% of dermatology trial participants live at least two hours from the trial site2, so by decentralizing, researchers can reach a more diverse and extensive pool of patients. 

Dermatology clinical research organizations and companies that have utilized a decentralized clinical trial approach have achieved a three-times faster patient enrollment and over 90% patient retention rates3.

Boost Revenue Growth

Book a demo to learn how.

    * - Required field

    Increase the Cost-efficiency of the Study

    Conventional clinical trials are time-consuming and expensive since they are conducted around research facilities that employ local patients.

    It is estimated that recruitment costs per patient for a clinical study are $6,500, and the average cost to recruit a new patient due to non-compliance is $19,5004. 

    According to Rosamund Round, VP of Patient Innovation Center and Decentralized Trials at Parexel 

    85% of all clinical trials fail to recruit enough patients, 80% are delayed due to recruitment problems5 

    Typically, dermatology clinical trials were designed around the research center where researchers could monitor the trial data of the patient pool. It was expected that trial participants travel to the facility to complete visits throughout the study, which disrupted their daily lives. 

    However, the long commute to the research facility represents the most significant barrier for patients to enroll in a clinical study or not6.

    Decentralized or hybrid clinical trials in dermatology follow a patient-centric approach by using digital health tools — virtual and wearable devices — to carry out remote visits and monitor data; this is convenient for patients and saves researchers costs.

    With decentralized clinical trials, patient monitoring and data collection are conducted remotely, so they do not need to commute to the site, eliminating this participation barrier constantly. 

    teledermatology's advantages

    What Is Teledermatology?

    Learn more about telehealth in dermatology.

    LEARN MORE

    Get More Accurate Outcomes

    Individuals experience the same disease and treatment differently. Clinical trials must include people with various characteristics, such as age, ethnicity, sex, eating habits, living conditions, and behaviors. This way, the clinical trial will consider the outcomes of all participants, and all communities will benefit from the scientific advances.

    However, clinical trials usually have inadequate recruitment of minority populations. Decentralized or hybrid clinical studies can potentially increase patient diversity due to the convenience they bring.

    For example, recruiting minorities is so challenging because traditional clinical trials often require patients to take time off from work, have a car, and navigate other inconveniences.

    Therefore, it is not surprising that these factors make clinical studies inaccessible to the individuals and communities who need them the most. Hybrid clinical studies in dermatology can remove these burdens.

    Reduce the Drug Time to Market

    Virtual clinical trials in dermatology and other medical specialties can significantly reduce patient attrition. On average, clinical trial participants have a dropout rate of 30% to 40% percent7. When participants perceive a high patient burden, the likelihood of dropping out of the trial is higher. 

    Frequent visits to the trial site increase dropout rates, whereas reduced site visits can help retain patients until the end of the trial.

    Decentralized dermatology trials focus on the patient experience and aim to relieve such burdens by utilizing remote patient monitoring technologies to collect patient data virtually.

    With a digital patient engagement solution, it is easier to keep dermatology patients engaged and motivated to remain in the trial until completion. 

    mobile apps for teledermatology

    Use of Mobile Applications in Dermatology

    Learn more about dermatology apps, their advantages, the usage trends, and the reasons why patients and clinicians need them.

    LEARN MORE

    A Platform for Decentralized Clinical Trials and Research in Dermatology

    A big challenge for dermatology researchers looking to conduct a virtual or hybrid clinical study can be finding the right digital health platform for the trial that can do everything they need  —securely gather patient-reported data, act as a communication channel between patients and researchers, and keep patients engaged— during the entire duration of the trial.

    Miiskin PRO is a skin health platform that enables patients to share information and high-resolution images of skin conditions, skin location, and the condition on a body map and fully customizable clinical questionnaires filled out by patients. 

    The Miiskin PRO platform consists of the Miiskin app for patients and a web portal for dermatological researchers. 

    The platform can be used for dermatology research and clinical studies that require digital patient-provider interventions and workflows using a high-quality skin imaging app in the hands of the patient. 

    The platform and app can be used for patient intervention research within the most common skin conditions such as melanoma, skin cancer, moles and lesions, rosacea, wound care, acne, psoriasis, and eczema, among others. 

    What type of patient-reported information can you include in your research?

    Miiskin PRO is fully customizable and can be configured to include all the information needed for clinical research. 

    The Miiskin app is powered by artificial intelligence, and it helps users document and track moles, lesions, and other chronic skin conditions over time. The app creates a photo log with the subject’s face and body photos allowing users and researchers to view the photos side by side on a screen.

    The Miiskin digital platform for dermatology research offers the following:

    • Automatic Skin Imagining to take full-body images
    • Face Tracking to take full-face images
    • Skin Mapping to visualize all the lesions and marks on the Skin
    • Mole Sizing to digitally measure and keep track of individual moles or skin lesions
    face photos multiangle
    Miiskin PRO taking a front picture using artificial intelligence

    Researchers can, for example, view the following information on the Miiskin digital platform:

    • Type of medication
    • Symptoms
    • Side effects
    • Patient images

    The digital health platform can also be customized to capture additional information related to the specific research. 

    miiskin pro teledermatology solution

    Does the platform provide patient consent?

    Yes, the Miiskin app also ensures that patients consent to share their photos and patient-reported information with the study’s researchers.

    Is the digital health platform easy to use? 

    The Miiskin app and the web portal are extremely easy to use for patients and researchers. It has an intuitive user interface and is fully customizable to fit your research or study.

    Is the platform secure and compliant? 

    Miiskin PRO is a secure and HIPAA-compliant digital healthcare platform. All information and images in the Miiskin app are encrypted so that no other app can access the information (PHI data) and pictures in your research. Besides, a PIN code can protect the patients’ photos. Researchers and providers can only access the encrypted PHI data through a personal provider login on our provider interface. 

    References:
    1 https://www.appliedclinicaltrialsonline.com/view/5-ways-dcts-can-positively-impact-trial-diversity
    2 https://www.mckinsey.com/industries/life-sciences/our-insights/no-place-like-home-stepping-up-the-decentralization-of-clinical-trials
    3 https://www.outsourcing-pharma.com/Article/2021/03/24/Advisory-council-works-to-amplify-patient-voice-inclusivity
    4 https://pubmed.ncbi.nlm.nih.gov/30264133/
    5 https://www.biopharmadive.com/spons/decentralized-clinical-trials-are-we-ready-to-make-the-leap/546591/
    6 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975097/
    7 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568443

    digital skin health miiskin

    Request Free Trial

      * - Required field

       

      customer experience dermatology clinic

      How to Improve Patient Experience with Teledermatology?

      Discover how telemedicine can help you boost the patient experience and satisfaction in your dermatology practice.

      LEARN MORE

      Miiskin App logo

      • Facebook
      • Twitter
      • Pinterest

      App Store Moles App

      Google Play Moles App

      Guides and Whitepapers

      Teledermatology

      Store-and-forward dermatology

      Reimbursement for teledermatology

      Dermatology apps

      Teledermatology jobs

      Dermatologists in Minneapolis, MN

      Service

      Mole & skin checking app

      Acne & skincare app

      Miiskin Premium

      For Independent Practices

      Frequently Asked Questions

      Help & Support

      Company

      About Miiskin

      Researchers

      Educational Content Information

      Media Kit & News

      Contact

      Careers

      Terms of Service · Privacy Policy · Cookie Policy · Miiskin © 2023Skin Health AllianceMiiskin Partners